Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $20.63B | $19.67B | +4.84% |
Gross Profit | $8.25B | $8.21B | +0.52% |
Operating Income | $2.76B | $2.63B | +5.26% |
Net Income | $2.08B | $1.99B | +4.57% |
EPS (Basic) | $4.56 | $4.37 | +4.35% |
EPS (Diluted) | $4.55 | $4.34 | +4.84% |
R&D Expense | $1.26B | $1.31B | -3.89% |
SG&A Expense | $4.22B | $4.27B | -1.03% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $36.91B | $33.09B | +11.54% |
Current Assets | $12.5B | $9.9B | +26.26% |
Total Liabilities | $26.31B | $24.44B | +7.65% |
Current Liabilities | $9.11B | $9.55B | -4.69% |
Stockholders' Equity | $10.38B | $8.45B | +22.89% |
Cash & Equivalents | $4.49B | $2.87B | +56.30% |
Long-Term Debt | $10B | $8.95B | +11.75% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Investing Cash Flow | $-1.05B | $-914M | -14.55% |
Financing Cash Flow | $617M | $-573M | +207.68% |
Dividends Paid | $64M | $55M | +16.36% |
Share Buybacks | $200M | $0 | — |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 40.0% | 41.7% | -1.72% |
Operating Margin | 13.4% | 13.3% | +0.05% |
Net Margin | 10.1% | — | — |
ROE | 20.1% | — | — |
ROA | 5.6% | — | — |
Current Ratio | $1.373 | — | — |
Debt to Equity | $2.535 | — | — |
GEHC demonstrated solid financial performance in 2025 with revenue and net income growth, despite slight margin pressures.
The company achieved a 4.8% increase in revenue, driven by strong sales in its core segments.
Source: Source: 10-K, Income Statement, p.1
SG&A expenses decreased by 1.0%, reflecting effective cost management strategies.
Source: Source: 10-K, Income Statement, p.1
R&D expenses decreased by 3.9%, indicating a potential shift in innovation strategy.
Source: Source: 10-K, Income Statement, p.1
The company's debt to equity ratio is 2.53, indicating a high level of leverage which could impact financial flexibility.
Source: Source: 10-K, Balance Sheet, p.1
Unlock 2 more detailed risk analysis
Upgrade to unlockOther companies in Health Care